Indication
Reversal of benzodiazepine-induced sedation
Reversal of benzodiazepine-induced sedation refers to the pharmacologic antagonism of central nervous system depression caused by benzodiazepines in adult and pediatric populations. Read more about Reversal of benzodiazepine-induced sedation
11 drugs 11 manufacturers
Drugs that treat it
Common Reversal of benzodiazepine-induced sedation therapies.
FLUMAZENIL
FLUMAZENIL
FLUMAZENIL
FLUMAZENIL
FLUMAZENIL
FLUMAZENIL
FLUMAZENIL
FLUMAZENIL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonReversal of benzodiazepine-induced sedation refers to the pharmacologic antagonism of central nervous system depression caused by benzodiazepines in adult and pediatric populations.
This clinical state typically arises following procedural conscious sedation, the induction or maintenance of general anesthesia, or unintentional oversedation and acute overdose.
Pathophysiologically, benzodiazepines allosterically modulate GABA_A receptors to augment gamma-aminobutyric acid inhibitory neurotransmission, leading to altered consciousness, somnolence, psychomotor impairment, and potential hypoventilation.
Therapeutic reversal targets the restoration of baseline alertness, airway protection, and spontaneous ventilation by competitively displacing these agents from their specific neuroreceptor binding sites.
- nih.gov
Reversal of benzodiazepine-induced sedation refers to the pharmacologic antagonism of central nervous system depression caused by benzodiazepines in adult and pediatric populations
- utah.edu
Reversal of benzodiazepine-induced sedation refers to the pharmacologic antagonism of central nervous system depression caused by benzodiazepines in adult and pediatric populations This clinical state typically arises following procedural conscious sedation, the induction or maintenance of general anesthesia, or unintentional oversedation and acute overdose Pathophysiologically, benzodiazepines allosterically modulate GABA_A receptors to augment gamma-aminobutyric acid inhibitory neurotransmissi...
- fda.gov
This clinical state typically arises following procedural conscious sedation, the induction or maintenance of general anesthesia, or unintentional oversedation and acute overdose
- drugbank.com
Pathophysiologically, benzodiazepines allosterically modulate GABA_A receptors to augment gamma-aminobutyric acid inhibitory neurotransmission, leading to altered consciousness, somnolence, psychomotor impairment, and potential hypoventilation Therapeutic reversal targets the restoration of baseline alertness, airway protection, and spontaneous ventilation by competitively displacing these agents from their specific neuroreceptor binding sites
- nih.gov
Pathophysiologically, benzodiazepines allosterically modulate GABA_A receptors to augment gamma-aminobutyric acid inhibitory neurotransmission, leading to altered consciousness, somnolence, psychomotor impairment, and potential hypoventilation
- sedationcertification.com
Therapeutic reversal targets the restoration of baseline alertness, airway protection, and spontaneous ventilation by competitively displacing these agents from their specific neuroreceptor binding sites
Personalize your experience
Follow Reversal of benzodiazepine-induced sedation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.